Efficiency of an mTOR Inhibitor in Kasabach-Merritt Phenomenon with Indolent Tufted Angioma: A Case Report

Acta Derm Venereol. 2017 Jul 6;97(7):851-852. doi: 10.2340/00015555-2597.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Hemangioma / diagnostic imaging
  • Hemangioma / drug therapy*
  • Hemangioma / enzymology
  • Humans
  • Infant
  • Kasabach-Merritt Syndrome / diagnostic imaging
  • Kasabach-Merritt Syndrome / drug therapy*
  • Kasabach-Merritt Syndrome / enzymology
  • Magnetic Resonance Imaging
  • Male
  • Protein Kinase Inhibitors / therapeutic use*
  • Sirolimus / therapeutic use*
  • Skin Neoplasms / diagnostic imaging
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / enzymology
  • TOR Serine-Threonine Kinases / antagonists & inhibitors*
  • TOR Serine-Threonine Kinases / metabolism
  • Treatment Outcome

Substances

  • Protein Kinase Inhibitors
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • Sirolimus

Supplementary concepts

  • Tufted angioma